Pharmagreen Biotech Market Risk Adjusted Performance
| PHBI Pink Sheet | | | USD 0.0015 -0.0002 -11.76% |
The Market Risk Adjusted Performance indicator for Pharmagreen Biotech is derived from observed market data. Exchange-specific data schedules may affect the recency of readings. Pharmagreen Biotech has a market cap of 2.96 M, current ratio of 0.1. Review
Your Equity Center for a broader allocation view. Adding Pharmagreen Biotech to a portfolio enables side-by-side comparison with other holdings. The information is presented without directional commentary. Broader economic conditions can influence Pharmagreen Biotech's company valuation — related indicators include
signals in bureau of labor statistics.
Pharmagreen Biotech has current Market Risk Adjusted Performance of
-0.16.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.16 | |
| ER[a] | = | Expected return on investing in Pharmagreen Biotech |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Pharmagreen Biotech is rated
below average for market risk adjusted performance among direct rivals. It is currently under evaluation for maximum drawdown among direct rivals .
Other Technical Indicators